DECRELEN

Welcome to the Brand page for “DECRELEN”, which is offered here for Pharmaceutical products for the treatment of cardiovascular diseases, central and peripheral nervous system diseases, respiratory diseases, cancer, allergies, gynecological diseases, rheumatic diseases, urological diseases, gastroenterological diseases, infectious diseases, eye diseases, dermatological diseases, autoimmune diseases, blood diseases, genital diseases, endocrine diseases, intestinal diseases, internal medicine diseases; hormones; vitamins; dietetic and food substances adapted for medical use;.

Its status is currently believed to be active. Its class is unavailable. “DECRELEN” is believed to be currently owned by “SANOFI BIOTECHNOLOGY”.

Owner:
SANOFI BIOTECHNOLOGY
Owner Details
Description:
Pharmaceutical products for the treatment of cardiovascular diseases, central and peripheral nervous system diseases, respiratory diseases, cancer, allergies, gynecological diseases, rheumatic diseases, urological diseases, gastroenterological diseases, infectious diseases, eye diseases, dermatological diseases, autoimmune diseases, blood diseases, genital diseases, endocrine diseases, intestinal diseases, internal medicine diseases; hormones; vitamins; dietetic and food substances adapted for medical use;
Categories: PHARMACEUTICAL PRODUCTS TREATMENT